294
Views
35
CrossRef citations to date
0
Altmetric
Review

Pertussis immunisation in adolescents and adults – Bordetella pertussis epidemiology should guide vaccination recommendations

&
Pages 685-697 | Published online: 29 Jun 2006

Bibliography

  • CHERRY JD, HEININGER U: Pertussis and other Bordetella infections. In: Textbook of Pediatric Infectious Diseases. 5th ed. Feigin RD, Cherry JD, Demmler GJ, Kaplan S (Eds), WB Saunders Co., Philadelphia, PA, USA (2004):1588-1608.
  • MATTOO S, CHERRY JD: Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. (2005) 18:326-382.
  • BARON S, NJAMKEPO E, GRIMPREL E et al.: Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr. Infect. Dis. J. (1998) 17:412-418.
  • GÜRIS D, STREBEL PM, BARDENHEIER B et al.: Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults, 1990–1996. Clin. Infect. Dis. (1999) 28:1230-1237.
  • CHERRY JD: Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin. Infect. Dis. (1999) 28(Suppl. 2):S112-S117.
  • DE MELKER HE, SCHELLEKENS JF, NEPPELENBROEK SE et al.: Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg. Infect. Dis. (2000) 6:348-357.
  • TANAKA M, VITEK CR, PASCUAL FB, BISGARD KM, TATE JE, MURPHY TV: Trends in pertussis among infants in the United States, 1980-1999. JAMA (2003) 290:2968-2975.
  • GZYL A, AUGUSTYNOWICZ E, RABCZENKO D, GNIADEK G, SLUSARCZYK J: Pertussis in Poland. Int. J. Epidemiol. (2004) 33:358-365.
  • MORTIMER EA: Pertussis and its prevention: a family affair. J. Infect. Dis. (1990) 161:473-479.
  • AOYAMA T, HARASHIMA M, NISHIMURA K, SAITO Y: Outbreak of pertussis in highly immunized adolescents and its secondary spread to their families. Acta Paediatr. Jpn. (1995) 37:321-324.
  • DE SERRES G, SHADMANI R, DUVAL B et al.: Morbidity of pertussis in adolescents and adults. J. Infect. Dis. (2000) 182:174-179.
  • MINK C, SIROTA NM, NUGENT S: Outbreak of pertussis in a fully immunized adolescent and adult population. Arch. Pediatr. Adolesc. Med. (1994) 148:153-157.
  • SENZILET LD, HALPERIN SY, SPIKA JS, ALAGARATNAM M, MORRIS A, SMITH B: Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Sentinel Health Unit Surveillance System Pertussis Working Group. Clin. Infect. Dis. (2001) 32:1691-1697.
  • YIH WK, LETT SM, DES VIGNES FN, GARRISON KM, SIPE PL, MARCHANT CD: The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998. J. Infect. Dis. (2000) 182:1409-1416.
  • BIRKEBAEK NH, KRISTIANSEN M, SEEFELDT T: Bordetella pertussis and chronic cough in adults. Clin. Infect. Dis. (1999) 29:1239-1242.
  • GILBERG S, NJAMKEPO E, DU CHÂTELET IP: Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J. Infect. Dis. (2002) 186:415-418.
  • LEE GM, LETT S, SCHAUER S: Massachusetts Pertussis Study Group. Societal costs and morbidity of pertussis in adolescents and adults. Clin. Infect. Dis. (2004) 39:1572-1580.
  • MINK C, CHERRY J, CHRISTENSON P: A search for Bordetella pertussis infection in university students. Clin. Infect. Dis. (1992) 14:464-471.
  • NENNIG ME, SHINEFIELD HR, EDWARDS KM, BLACK SB, FIREMAN BH: Prevalence and incidence of adult pertussis in an urban population. JAMA (1996) 275:1672-1674.
  • POSTELS-MULTANI S, SCHMITT HJ, WIRSING VON KÖNIG CH, BOCK HL, BOGAERTS H: Symptoms and complications of pertussis in adults. Infection (1995) 23:139-142.
  • SCHMITT-GROHÉ S, CHERRY, JD, HEININGER U, ÜBERALL MA, PINEDA E, STEHR K: Pertussis in German adults. Clin. Infect. Dis. (1995) 21:860-866.
  • CHERRY JD: The epidemiology of pertussis and pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics (2005) 115:1422-1427.
  • JACKSON LA, CHERRY JD, WANG SP, GRAYSTON JT: Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin. Infect. Dis. (2000) 31:3-6.
  • ROBERTSON PW, GOLDBERG H, JARVIE BH, SMITH DD, WHYBIN LR: Bordetella pertussis infection: a cause of persistent cough in adults. Med. J. Aust. (1987) 146:522-525.
  • WRIGHT SW, EDWARDS KM, DECKER MD, ZELDIN MH: Pertussis infection in adults with persistent cough. JAMA (1995) 273:1044-1046.
  • WIRSING VON KÖNIG CH, POSTELS-MULTANI S, BOCK HL, SCHMITT HJ: Pertussis in adults: frequency of transmission after household exposure. Lancet (1995) 346:1326-1329.
  • ROSENTHAL S, STREBEL P, CASSIDAY P, SANDEN G, BRUSUELAS K, WHARTON M: Pertussis infection among adults during the 1993 outbreak in Chicago. J. Infect. Dis. (1995) 171:1650-1652.
  • JANSEN DL, GRAY GC, PUTNAM SD, LYNN F, MEADE BD: Evaluation of pertussis in US Marine Corps trainees. Clin. Infect. Dis. (1997) 25:1099-1107.
  • STREBEL P, NORDIN J, EDWARDS K et al.: Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995–1996. J. Infect. Dis. (2001) 183:1353-1359.
  • VINCENT JM, CHERRY JD, NAUSCHUETZ WF et al.: Prolonged afebrile non-productive cough illnesses in American soldiers in Korea: a serological search for causation. Clin. Infect. Dis. (2000) 30:534-539.
  • MERTENS PL, STALS FS, SCHELLEKENS JF, HOUBEN AW, HUISMAN J: An epidemic of pertussis among elderly people in a religious institution in The Netherlands. Eur. J. Clin. Microbiol. Infect. Dis. (1999) 18:242-247.
  • WARD JI, CHERRY JD, CHANG SJ et al.: Efficacy of an acellular pertussis vaccine among adolescents and adults. N. Engl. J. Med. (2005) 353:1555-1563.
  • GREENBERG DP: Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr. Infect. Dis. J. (2005) 24:721-728.
  • EDWARDS KM: Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended? (editorial) Clin. Infect. Dis. (2001) 32:1698-1699.
  • CHERRY JD: The science and fiction of the ‘resurgence’ of pertussis. Pediatrics (2003) 112:405-406.
  • HENNES H: Der Keuchhusten bei Erwachsenen. Med. Klinik (1921) 17:591-593.
  • NELSON JD: The changing epidemiology of pertussis in young infants: The role of adults as reservoirs of infection. Am. J. Dis. Child. (1978) 132:371-375.
  • FARIZO KM, COCHI SL, ZELL ER, BRINK EW, WASSILAK SG, PATRIARCA PA: Epidemiological features of pertussis in the United States, 1980–1989. Clin. Infect. Dis. (1992) 14:708-719.
  • WIRSING VON KÖNIG CH, HALPERIN S, RIFFELMANN M, GUISO N: Pertussis of adults and infants. Lancet Infect. Dis. (2002) 2:744-750.
  • DEEN JL, MINK CA, CHERRY JD et al.: Household contact study of Bordetella pertussis infections. Clin. Infect. Dis. (1995) 21:1211-1219.
  • CHERRY JD: The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr. Probl. Pediatr. (1984) 14:1-78.
  • FINE PE, CLARKSON JA: The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet (1982) 1:666-669.
  • CELENTANO LP, MASSARI M, PARAMATTI D, SALMASO S, TOZZI AE: Resurgence of pertussis in Europe. Pediatr. Infect. Dis. J. (2005) 24:761-765.
  • CENTERS FOR DISEASECONTROL: Annual summary 1984: reported morbidity and mortality in the United States. MMWR Morb. Mortal. Weekly Rep. (1986) 33(54):1-135.
  • MARCHANT CD, LOUGHLIN AM, LETT SM et al.: Pertussis in Massachusetts, 1981–1991: incidence, serologic diagnosis, and vaccine effectiveness. J. Infect. Dis. (1994) 169:1297-1305.
  • MOOI FR, VAN LOO IH, KING AJ: Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg. Infect. Dis. (2001) 7:526-528.
  • DENOËL P, GODFROID F, GUISO N, HALLANDER H, POOLMAN J: Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model. Vaccine (2005) 23:5333-5341.
  • GUISO N: Is Bordetella pertussis changing? ASM News (2005) 71:230-234.
  • GRECO D, SALMASO S, MASTRANTONIO P et al.: A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N. Engl. J. Med. (1996) 334:341-348.
  • GUSTAFSSON L, HALLANDER HO, OLIN P, REIZENSTEIN E, STORSAETER J: A controlled trial of a two-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. (1996) 334:349-355.
  • BISGARD KM, RHODES P, CONNELLY BL et al.: Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998–2001. Pediatrics (2005) 116:285-294.
  • NICOLL A, GARDNER A: Whooping cough and unrecognised postperinatal mortality. Arch. Dis. Child. (1988) 63:41-47.
  • CROWCROFT NS, ANDREWS N, ROONEY C, BRISSON M, MILLER E: Deaths from pertussis are underestimated in England. Arch. Dis. Child. (2002) 86:336-338.
  • CROWCROFT NS, BOOY R, HARRISON T et al.: Severe and unrecognised: pertussis in UK infants. Arch. Dis. Child. (2003) 88:802-806.
  • VITEK CR, PASCUAL FB, BAUGHMAN AL, MURPHY TV: Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr. Infect. Dis. J. (2003) 22:628-634.
  • CHERRY JD: The epidemiology of pertussis. Pediatr. Infect. Dis. J. (2006) 25(4):361-362.
  • DEVILLE JG, CHERRY JD, CHRISTENSON PD: Frequency of unrecognized Bordetella pertussis infections in adults. Clin. Infect. Dis. (1995) 21:639-642.
  • CROMER BA, GOYDOS J, HACKELL J, MEZZATESTA J, DEKKER C, MORTIMER EA: Unrecognized pertussis infection in adolescents. Am. J. Dis. Child. (1993) 147:575-577.
  • HODDER SL, CHERRY JD, MORTIMER EA JR, FORD AB, GORNBEIN J, PAPP K: Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin. Infect. Dis. (2000) 31:7-14.
  • WRIGHT SW, DECKER MD, EDWARDS KM: Incidence of pertussis infection in healthcare workers. Infect. Control Hosp. Epidemiol. (1999) 20:120-123.
  • DE MELKER HE, VERSTEEGH FG, SCHELLEKENS JF, TEUNIS PF, KRETZSCHMAR M: The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J. Infect. (2005) (In Press).
  • LINNEMANN CC JR, NASENBENY J: Pertussis in the adult. Annu. Rev. Med. (1977) 28:179-185.
  • EDWARDS KM: Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr. Infect. Dis. J. (2005) 24(6 Suppl.):S104-S108.
  • SCHELLEKENS J, VON KONIG CH, GARDNER P: Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr. Infect. Dis. J. (2005) 24(5 Suppl.):S19-S24.
  • BISGARD KM, PASCUAL FB, EHRESMANN KR: Infant pertussis: who was the source? Pediatr. Infect. Dis. J. (2004) 23:985-989.
  • MERCHANT CD: The 100-day cough: the time for prevention has arrived. Clin. Infect. Dis. (2004) 39:1581-1582.
  • HOPPE JE: Keuchhusten bei Schwangeren und Neugeborenen. Z. Geburtsh. Neonatol. (1996) 200:241-244.
  • IZURIETA HS, KENYON TA, STREBEL PM, BAUGHMAN AL, SHULMAN ST, WHARTON M: Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin. Infect. Dis. (1996) 22:503-507.
  • KURT TL, YEAGER AS, GUENETTE S, DUNLOP S: Spread of pertussis by hospital staff. JAMA (1972) 221:264-267.
  • SHEFER A, DALES L, NELSON M, WERNER B, BARON R, JACKSON R: Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis. J. Infect. Dis. (1995) 171:1053-1056.
  • GEHANNO JF, PESTEL-CARON M, NOUVELLON M, CAILLARD JF: Nosocomial pertussis in healthcare workers from a pediatric emergency unit in France. Infect. Control. Hosp. Epidemiol. (1999) 20:549-552.
  • NOUVELLON M, GEHANNO JF, PESTEL-CARON M, WEBER C, LEMELAND JF, GUISO N: Usefulness of pulsed-field gel electrophoresis in assessing nosocomial transmission of pertussis. Infect. Control Hosp. Epidemiol. (1999) 20:758-760.
  • HALPERIN SA, MARRIE TJ: Pertussis encephalopathy in an adult: case report and review. Rev. Infect. Dis. (1991) 13:1043-1047.
  • GIL A, OYAGUEZ I, CARRASCO P, GONZALEZ A: Hospital admissions for pertussis in Spain, 1995 –1998. Vaccine (2001) 19:4791-4794.
  • CENTERS FOR DISEASECONTROL AND PREVENTION: Fatal case of unsuspected pertussis diagnosed from a blood culture – Minnesota, 2003. MMWR Morb. Mortal. Weekly Rep. (2004) 53:131-132.
  • BONHOEFFER J, BAR G, RIFFELMANN M, SOLER M, HEININGER U: The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis. Infection (2005) 33:13-17.
  • LEE LH, PICHICHERO ME: Costs of illness due to Bordetella pertussis in families. Arch. Fam. Med. (2000) 9:989-996.
  • MÜLLER FM, HOPPE JE, WIRSING VON KÖNIG CH: Laboratory diagnosis of pertussis: state of the art in 1997. J. Clin. Microbiol. (1997) 35:2435-2443.
  • HEININGER U, SCHMIDT-SCHLÄPFER G, CHERRY JD, STEHR K: Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics (2000) 105:31.
  • TEMPLETON KE, SCHELTINGA SA, VAN DER ZEE A et al.: Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J. Clin. Microbiol. (2003) 41:4121-4126.
  • HALLANDER HO: Microbiological and serological diagnosis of pertussis. Clin. Infect. Dis. (1999) 28(Suppl. 2):S99-S106.
  • MANCLARK C, MEADE DB, BURSTYN DG: Serological response to Bordetella pertussis. In: Manual of Clinical Laboratory Immunology. 3rd ed. Rose NR, Friedman H, Fahey JK (Eds), American Society for Microbiology, Washington, DC, USA (1986):388-394.
  • STEHR K, CHERRY JD, HEININGER U et al.: A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DtaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics (1998) 101:1-11.
  • SCHMITT HJ, WIRSING VON KÖNIG CH, NEISS A et al.: Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA (1996) 275:37-41.
  • PRINCE HE, LAPE-NIXON, MATUD J: Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies. Clin. Vaccine Immunol. (2006) 13:266-270.
  • HOPPE JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. The Erythromycin Study Group. Pediatr. Infect. Dis. J. (1992) 11:189-193.
  • HOPPE J, EICHHORN A: Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis. Eur. J. Clin. Microbiol. Infect. Dis. (1989) 8:653-654.
  • HALPERIN, SA, BORTOLUSSI R, LANGLEY JM, MILLER B, EASTWOOD BJ: Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. Pediatrics (1997) 100:65-71.
  • BASS JW, KLENK EL, KOTHEIMER JB, LINNEMANN CC, SMITH MH: Antimicrobial treatment of pertussis. J. Pediatr. (1969) 75:768-781.
  • BERGQUIST SO, BERNANDER S, DAHNSJO H, SUNDELOF B: Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr. Infect. Dis. J. (1987) 6:458-461.
  • GÜRIS D: Treatment and Chemoprophylaxis, Guidelines for the control of pertussis outbreaks. Centers for Disease Control and Prevention, Atlanta, GA, USA (2000).
  • HEININGER U, CHERRY JD, ECKHARDT T, LORENZ C, CHRISTENSON P, STEHR K: Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. Pediatr. Infect. Dis. J. (1993) 12:504-509.
  • HEININGER U, CHERRY JD, STEHR K et al.: Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study Group. Pediatrics (1998) 102:546-553.
  • OLIN P, GUSTAFSSON L, BARRETO L et al.: Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine (2003) 21:2015-2021.
  • SALMASO S, MASTRANTONIO P, TOZZI AE et al.: Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics (2001) 108:E81.
  • SALMASO S, MASTRANTONIO P, WASSILAK SG et al.: Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group. Vaccine (1998) 16:1270-1275.
  • LUGAUER S, HEININGER U, CHERRY JD, STEHR K: Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur. J. Pediatr. (2002) 161:142-146.
  • FORSYTH KD, CAMPINS-MARTI M, CARO J et al.: New pertussis vaccination strategies beyond infancy: recommendations by the Global Pertussis Initiative. Clin. Infect. Dis. (2004) 39:1802-1809.
  • BEGUE PC, GRIMPREL EM, GIOVANNANGELI MD, ABITBOL VI: Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents. Pediatr. Infect. Dis. J. (1998) 17:804-819.
  • MINH NN, HE Q, RAMALHO A et al.: Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents. Pediatrics (1999) 104:e70.
  • HALPERIN SA, SMITH B, RUSSELL M et al.: Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr. Infect. Dis. J. (2000) 19:276-283.
  • VERGARA R, TREGNAGHI M, USSHER J et al.: Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age. Eur. J. Pediatr. (2005) 164:377-382.
  • THEETEN H, VAN DAMME P, HOPPENBROUWERS K et al.: Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents. Vaccine (2005) 23:1515-1521.
  • PICHICHERO ME, RENNELS MB, EDWARDS KM et al.: Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA (2005) 293:3003-3011.
  • SOUTHERN J, ANDREWS N, BURRAGE M, MILLER E: Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers. Vaccine (2005) 23:3829-3835.
  • RENNELS MB, DELORIA MA, PICHICHERO ME et al.: Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics (2000) 105:e12.
  • CHERRY JD: Pertussis vaccines for adolescents and adults. Pediatrics (2005) 116:755-756.
  • HEININGER U: Recent progress in clinical and basic pertussis research. Eur. J. Pediatr. (2001) 160:203-213.

Websites

  • http://www.cdc.gov/nip/vaccine/tdap/ default.htm Bacterial Vaccine-Preventable Disease Branch, National Immunization Program, Centers for Disease Control and Prevention. Pertussis surveillance report – 8/12/05.
  • http://www.fda.gov/ohrms/dockets/ac/05/ briefing/2005-4097b1.htm Food and Drug Administration, Vaccines and Related Biological Products Advisory Committee, 15 March 2005, Briefing Information.
  • http://www-nt.who.int/immunization_ monitoring/en/globalsummary/ countryprofileselect.cfm WHO Vaccine Preventable Diseases Monitoring System, country profile selection centre.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.